248 related articles for article (PubMed ID: 22384166)
1. Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.
Borkosky SS; Whitley C; Kopp-Schneider A; zur Hausen H; de Villiers EM
PLoS One; 2012; 7(2):e32160. PubMed ID: 22384166
[TBL] [Abstract][Full Text] [Related]
2. Detection of Torque teno virus in Epstein-Barr virus positive and negative lymph nodes of patients with Hodgkin lymphoma.
Figueiredo CP; Franz-Vasconcelos HC; Giunta Gd; Mazzuco TL; Caon T; Fernandes AL; Simões CM; Antunes VL; Niel C; Barardi CR
Leuk Lymphoma; 2007 Apr; 48(4):731-5. PubMed ID: 17454631
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
Leinbach SS; Summers WC
J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
[TBL] [Abstract][Full Text] [Related]
5. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection.
Garbuglia AR; Iezzi T; Capobianchi MR; Pignoloni P; Pulsoni A; Sourdis J; Pescarmona E; Vitolo D; Mandelli F
Int J Immunopathol Pharmacol; 2003; 16(2):109-18. PubMed ID: 12797901
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
Simbiri KO; Smith NA; Otieno R; Wohlford EE; Daud II; Odada SP; Middleton F; Rochford R
PLoS One; 2015; 10(5):e0125420. PubMed ID: 25933165
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
8. The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT).
Schmitz J; Kobbe G; Kondakci M; Schuler E; Magorsch M; Adams O
Biol Blood Marrow Transplant; 2020 Apr; 26(4):643-650. PubMed ID: 31712192
[TBL] [Abstract][Full Text] [Related]
9. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
Gutierrez MI; Bhatia K; Magrath I
Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.
Arcenas R; Widen RH
BMC Microbiol; 2002 Jul; 2():20. PubMed ID: 12137568
[TBL] [Abstract][Full Text] [Related]
11. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
12. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
Marchini A; Longnecker R; Kieff E
J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
Kennedy G; Komano J; Sugden B
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
[TBL] [Abstract][Full Text] [Related]
18. Strong association of Torque teno virus/Torque teno-like minivirus to Kikuchi-Fujimoto lymphadenitis (histiocytic necrotizing lymphadenitis) on quantitative analysis.
Chong Y; Lee JY; Thakur N; Kang CS; Lee EJ
Clin Rheumatol; 2020 Mar; 39(3):925-931. PubMed ID: 31782015
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma.
Okano M; Mizuno F; Osato T
J Infect; 1995 Jul; 31(1):15-9. PubMed ID: 8522826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
